These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cardiac metastasis from renal cell carcinoma successfully treated with pazopanib: impact of TKIs' antiangiogenic activity. Schinzari G, Monterisi S, Signorelli D, Cona MS, Cassano A, Danza F, Barone C. Tumori; 2014; 100(6):e298-300. PubMed ID: 25688515 [Abstract] [Full Text] [Related]
3. Successful re-administration of Pazopanib in a patient with metastatic renal cell carcinoma and a history of Pazopanib-induced nephrotic syndrome: a case report. Jeon SY, Lee NR, Yim CY. BMC Nephrol; 2019 Jan 03; 20(1):1. PubMed ID: 30606155 [Abstract] [Full Text] [Related]
4. Prognosis of patients with metastatic renal cell carcinoma and pancreatic metastases. Kalra S, Atkinson BJ, Matrana MR, Matin SF, Wood CG, Karam JA, Tamboli P, Sircar K, Rao P, Corn PG, Tannir NM, Jonasch E. BJU Int; 2016 May 03; 117(5):761-5. PubMed ID: 26032863 [Abstract] [Full Text] [Related]
5. Persistence and compliance with pazopanib in patients with advanced renal cell carcinoma within a U.S. administrative claims database. Hackshaw MD, Nagar SP, Parks DC, Miller LA. J Manag Care Spec Pharm; 2014 Jun 03; 20(6):603-10. PubMed ID: 24856598 [Abstract] [Full Text] [Related]
9. Severe hyperglycaemia following pazopanib treatment: The role of drug-drug-gene interactions in a patient with metastatic renal cell carcinoma-A case report. Kuruc Poje D, Božina N, Šimičević L, Žabić I. J Clin Pharm Ther; 2020 Aug 03; 45(4):628-631. PubMed ID: 32369219 [Abstract] [Full Text] [Related]
11. Symptomatic cardiac metastasis responding to pazopanib in a patient with renal cell carcinoma. Behzadigohar R, Rosenthal MA, Tran B. Can J Urol; 2015 Jun 03; 22(3):7824-6. PubMed ID: 26068633 [Abstract] [Full Text] [Related]